NYSE:INSP Inspire Medical Systems (INSP) Stock Price, News & Analysis $70.48 -0.02 (-0.03%) Closing price 09/25/2026 03:59 PM EasternExtended Trading$70.50 +0.02 (+0.04%) As of 09/25/2026 07:30 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsInsider TradesNews and TrendsOptions ChainOwnershipSEC FilingsShort Interest About Inspire Medical Systems Stock (NYSE:INSP) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get INSP alerts:Sign Up Key Stats Today's Range$68.13▼$70.9850-Day Range$49.38▼$76.8552-Week Range$38.91▼$147.03Volume609,837 shsAverage Volume806,236 shsMarket Capitalization$2.04 billionP/E Ratio15.26Dividend YieldN/APrice Target$66.50Consensus RatingHold Company Overview Inspire Medical Systems, Inc. develops and commercializes medical devices for treating moderate to severe obstructive sleep apnea (OSA), a condition in which the upper airway repeatedly becomes blocked during sleep. The company’s primary product is Inspire therapy, an implantable system designed for patients who are unable to use or obtain consistent benefit from continuous positive airway pressure (CPAP) therapy. The Inspire system uses a small implantable pulse generator, a breathing-sensing lead and a stimulation lead. It monitors the patient’s breathing pattern and delivers mild electrical stimulation to the hypoglossal nerve, helping keep the airway open during sleep. Patients generally activate and control the system with a handheld remote, while physicians use related programming and monitoring tools to tailor treatment. Founded in 2007 and headquartered in Golden Valley, Minnesota, Inspire Medical Systems received U.S. Food and Drug Administration approval for its therapy in 2014. The company sells its products primarily through a direct commercial organization and works with physicians, sleep centers and healthcare providers. Its operations and commercial presence extend beyond the United States to selected international markets, including parts of Europe.AI Generated. May Contain Errors. Read More Inspire Medical Systems Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks51st Percentile Overall ScoreINSP MarketRank™: Inspire Medical Systems scored higher than 51% of companies evaluated by MarketBeat, and ranked 512th out of 903 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion2.1 / 5Analyst RatingHold Consensus RatingInspire Medical Systems has received a consensus rating of Hold. The company's average rating score is 2.11, and is based on 1 strong buy rating, 3 buy ratings, 12 hold ratings, and 3 sell ratings.Downside RiskInspire Medical Systems has a consensus price target of $66.50, representing about 5.6% downside from its current price of $70.48.Amount of Analyst CoverageInspire Medical Systems has been the subject of 13 research reports in the past 90 days, demonstrating strong analyst interest in this stock.Read more about Inspire Medical Systems' stock forecast and price target. Earnings and Valuation3.1 / 5Proj. Earnings Growth25.00% Earnings GrowthEarnings for Inspire Medical Systems are expected to grow by 25.00% in the coming year, from $1.24 to $1.55 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Inspire Medical Systems is 15.26, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 38.91.Price to Earnings Ratio vs. SectorThe P/E ratio of Inspire Medical Systems is 15.26, which means that it is trading at a less expensive P/E ratio than the Healthcare sector average P/E ratio of about 276.12.Price to Earnings Growth RatioInspire Medical Systems has a PEG Ratio of 5.33. PEG Ratios above 1 indicate that a company could be overvalued.Price to Book Value per Share RatioInspire Medical Systems has a P/B Ratio of 2.62. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.Read more about Inspire Medical Systems' valuation and earnings. Short Interest1.0 / 5Short Interest LevelBearish Percentage of Shares Shorted13.89% of the float of Inspire Medical Systems has been sold short.Short Interest Ratio / Days to CoverInspire Medical Systems has a short interest ratio ("days to cover") of 4.94.Change versus previous monthShort interest in Inspire Medical Systems has recently increased by 7.43%, indicating that investor sentiment is decreasing significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldInspire Medical Systems does not currently pay a dividend.Dividend GrowthInspire Medical Systems does not have a long track record of dividend growth. News and Social Media3.1 / 5News Sentiment0.90 News SentimentInspire Medical Systems has a news sentiment score of 0.90. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.74 average news sentiment score of Healthcare companies.News Coverage This WeekMarketBeat has tracked 6 news articles for Inspire Medical Systems this week, compared to 8 articles on an average week.MarketBeat Follows5 people have added Inspire Medical Systems to their MarketBeat watchlist in the last 30 days. This is an increase of 150% compared to the previous 30 days. Company Ownership1.5 / 5Insider TradingSelling Shares Insider Buying vs. Insider SellingIn the past three months, Inspire Medical Systems insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $57,347.00 in company stock.Percentage Held by Insiders2.20% of the stock of Inspire Medical Systems is held by insiders.Percentage Held by Institutions94.91% of the stock of Inspire Medical Systems is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Inspire Medical Systems' insider trading history. Receive INSP Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Inspire Medical Systems and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. INSP Stock News HeadlinesAnalysts’ Opinions Are Mixed on These Healthcare Stocks: Inspire Medical Systems (INSP) and Ramsay Health Care (OtherRMSYF)September 24, 2026 | theglobeandmail.comIs It Too Late to Buy Inspire Medical Systems Inc (INSP) After 5.5% Rally? GF Value Says UndervaluedSeptember 18, 2026 | gurufocus.comIf you keep cash in a U.S. bank account… read this NOWSince 2020, U.S. banks have been required to keep zero percent of deposits on hand, lending out nearly every dollar while paying savers just 0.04 percent interest. A new law, the GENIUS Act signed last summer, has cleared the way for a different kind of money to emerge this fall, one that could offer savings rates up to 6 percent. See what Ian King, Chief Strategist at Strategic Fortunes, has uncovered about this shift before it goes live. | Banyan Hill Publishing (Ad)Inspire Medical Systems (INSP) Stock Could Be 14% Undervalued On Cash FlowSeptember 15, 2026 | finance.yahoo.comZacks Industry Outlook Medical Systems, American Well and Butterfly NetworkSeptember 14, 2026 | uk.finance.yahoo.comWhy Inspire Medical Systems (INSP) stock is up todaySeptember 11, 2026 | msn.comInspire Medical Systems (INSP): Buy, sell, or hold post Q2 earnings?September 4, 2026 | msn.comInspire Medical Systems, Inc. to Present at the Wells Fargo 21st Annual Healthcare ConferenceAugust 26, 2026 | globenewswire.comSee More Headlines INSP Stock Analysis - Frequently Asked Questions How have INSP shares performed this year? Inspire Medical Systems' stock was trading at $92.20 at the beginning of the year. Since then, INSP shares have decreased by 23.6% and is now trading at $70.48. How were Inspire Medical Systems' earnings last quarter? Inspire Medical Systems, Inc. (NYSE:INSP) issued its earnings results on Monday, August, 3rd. The company reported $0.14 EPS for the quarter, beating analysts' consensus estimates of ($0.24) by $0.38. Inspire Medical Systems's revenue for the quarter was down 7.6% compared to the same quarter last year. Read the conference call transcript. How will Inspire Medical Systems' stock buyback program work? Inspire Medical Systems' Board of Directors initiated a stock buyback plan on Monday, August 11th 2025, which authorizes the company to buy back $200,000,000 in shares, according to EventVestor. This means that the company could buy up to 8.6% of its shares through open market purchases. Shares repurchase plans are typically an indication that the company's management believes its stock is undervalued. When did Inspire Medical Systems IPO? Inspire Medical Systems (INSP) raised $101 million in an initial public offering (IPO) on Thursday, May 3rd 2018. The company issued 6,750,000 shares at a price of $14.00-$16.00 per share. BofA Merrill Lynch and Goldman Sachs served as the underwriters for the IPO and Guggenheim Securities, Stifel and Wells Fargo Securities were co-managers. Who are Inspire Medical Systems' major shareholders? Top institutional shareholders of Inspire Medical Systems include BlackRock Inc. (16.39%), Wellington Management Group LLP (8.24%), Assenagon Asset Management S.A. (3.00%) and UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC (1.89%). Insiders that own company stock include Timothy P Herbert, Richard Buchholz, Shawn Mccormick, Jason P Kelly, John Rondoni, Jerry C Griffin, Randy Ban and Myriam Curet. View institutional ownership trends. How do I buy shares of Inspire Medical Systems? Shares of INSP stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Inspire Medical Systems own? Based on aggregate information from My MarketBeat watchlists, some other companies that Inspire Medical Systems investors own include NVIDIA (NVDA), Meta Platforms (META), Advanced Micro Devices (AMD), UnitedHealth Group (UNH), Tesla (TSLA), CrowdStrike (CRWD) and Johnson & Johnson (JNJ). Company Calendar Last Earnings8/03/2026Today9/27/2026Next Earnings (Estimated)11/02/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Green Zone (1m+) 1-Year History Sep 25 Dec 25 Mar 26 Jun 26 Sep 26 INSP's financial health is in the Green zone, according to TradeSmith. INSP has been in this zone for over one month. Industry, Sector and Symbol Stock ExchangeNYSE SectorHealthcare Industry Healthcare Equipment & Supplies Sub-IndustryHealthcare Equipment Current SymbolNYSE:INSP CIK1609550 Webwww.inspiresleep.com Phone(844) 672-4357FaxN/AEmployees1,333Year Founded2007Price Target and Rating Average Price Target for Inspire Medical Systems$66.50 High Price Target$180.00 Low Price Target$39.00 Potential Upside/Downside-5.6%Consensus RatingHold Rating Score (0-4)2.11 Research Coverage19 Analysts Profitability EPS (Trailing Twelve Months)$4.62 Trailing P/E Ratio15.26 Forward P/E Ratio56.84 P/E Growth5.33Net Income$145.42 million Net Margins15.03% Pretax Margin7.72% Return on Equity8.64% Return on Assets7.45% Debt Debt-to-Equity RatioN/A Current Ratio8.55 Quick Ratio6.16 Sales & Book Value Annual Sales$911.98 million Price / Sales2.23 Cash Flow$2.86 per share Price / Cash Flow24.62 Book Value$26.88 per share Price / Book2.62Miscellaneous Outstanding Shares28,910,000Free Float28,274,000Market Cap$2.04 billion OptionableOptionable Beta0.70 Social Links 7 Stocks That Will Be Magnificent in 2026Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2026. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.Get This Free Report This page (NYSE:INSP) was last updated on 9/28/2026 by MarketBeat.com Staff. From Our PartnersArizona Gold Explorer Nears First-Ever Resource EstimateA little-known Arizona gold explorer just hit 66.2 metres grading 6.57 g/t gold, including 20.7 metres at 18.2...Wall Street Logic | SponsoredMy next big call (under $1)17,556% on KDA. Here's what I'm buying now. It's a coin under $1.00 that most investors have never heard of...Crypto 101 Media | Sponsored"How Much Can I Actually Spend Each Year With $2.5M Saved?"Having $2.5 million saved puts you ahead of most Americans, but how long it lasts depends on the decisions you...SmartAsset | SponsoredMusk says UBI is coming. I say it's already here.Elon Musk says AI could make money irrelevant by 2036. One income program already exists today, funded not by ...Freedom Financial | SponsoredWhy major institutions are piling into this digital asset nowBlackRock, JPMorgan, Goldman Sachs, and Fidelity are reportedly accumulating a scarce blockchain asset - one t...Awesomely | SponsoredTrump's New DollarPorter Stansberry says President Trump has signed an executive order initiating what he calls a full U.S. doll...Porter & Company | SponsoredCODE RED: AI Meltdown Imminent?After correctly predicting the 2008 and 2020 stock market meltdowns, I believe this AI company is about to tri...Paradigm Press | SponsoredThis AI Stock Reminds One Analyst of Early NvidiaJeff Brown picked Nvidia in 2016, before shares surged 37,800 percent. Now he's identified another AI company ...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Inspire Medical Systems, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Inspire Medical Systems With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.